1Venn A,Watson L,Lumley J,et al.Brest and ovarian cancer incidence after infertility and in vitro fertilization[J].Lancet,1995,346:995-1000.
2Ali M,Tanja,Farr N.Induction of ovulation and ovarian cancer:a critical review of the literature[J].Fertil Steril,2006,85(4):819-826.
3Franco C,Coppola S,Prosperi PR,et al.Ovulation induction and the risk of ovarian tumors[J].Minerva Ginecol,2000,52(4):103-109.
4Clinton GM,Hua W.Estrogen action in human ovarian cancer[J].Crit Rev Oncol Hematol,1997,25:1-9.
5Venn A,Watson L,Bruinsma F,et al.Risk of cancer after use of fertility drugs with in-vitro fertilisation[J].Lancet,1999,354(9190):1586-1590.
6Dor J,Lerner-G,Rabinovici J,et al.Cancer incidence in a cohort of infertile women who underwent in vitro fertilization[J].Fertil Steril,2002,77 (2):324-327.
7Venn A,Jones P,Quinn M,et al.Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients[J].Gynecol Oncol,2001,82(1):64-68.
8Ayhan A,Salman MC,Celik H,et al.Association between fertility drugs and gynecologic cancers,breast cancer,and childhood cancers[J].Acta Obstet Gynecol Scand,2004,83 (12):1104-1111.
9Brinton LA,Lamb EJ,Moghissi KS,et al.Ovarian cancer risk after the use of ovulation-stimulating drugs[J].Obstet Gynecol,2004,103(6):1194-1203.
10Klip H,Burger CW,Kenernans P,et al.Cancer risk associated with subfertility and ovulation induction:a review[J].Cancer Causes Control,2000,11 (4):319-344.
二级参考文献16
1Mikkelson AL,Smith S,Lindenberg S.Impact of oestradiol and inhibin A concentrations on pregnancy rate in in-vitro oocyte maturation.Hum Reprod,2000,15:1685-1690.
2Rubio Pomar FJ,Roelen BA,Slot KA,et al.Role of Fas-mediated apoptosis and follicle-stimulating hormone on the developmental capacity of bovine cumulus oocyte complexes in vitro.Biol Reprod,2004,71:790-796.
3Sutton-McDowall ML,Gilchrist RB,Thompson JG.Cumulus expansion and glucose utilisation by bovine cumulus-oocyte complexes during in vitro maturation: the influence of glucosamine and follicle-stimulating hormone.Reproduction,2004,128:313-319.
4Suikkari AM,Tulppala M,Tuuri T,et al.Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery,maturation and fertilization of immature human oocytes.Hum Reprod,2000,15: 747-751.
5Wynn P,Picton HM,Krapez JA,et al.Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation.Hum Reprod,1998,13: 3132-3138.
6Mikkelsen AL,Lindenberg S.Benefit of FSH priming of women with PCOS to the in-vitro maturation procedure and the outcome: a randomized prospective study.Reproduction,2001,122:587-592.
7Lin YH,Hwang JL,Huang LW,et al.Combination of FSH priming nad hCG priming for in-vitro maturation of human oocytes.Hum Reprod,2003,18:1632-1636.
8Chian RC,Guleki B,Buckett WM,et al.Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to polycystic ovary syndrome.N Engl J Med,1999,341:1624-1626.
9Fukuda A,Nakaoka Y,Tohnaka M,et al.Establishment of in vitro maturation system (IVM-IVF) as a routine ART procedure by combination of HCG administration and frozen-thawed embryo transfer.Fertil Steril,2002,78(Suppl 1): 232.
10Hreinsson J,Rosenlund B,Friden B,et al.Recombination LH is equally effective as recombinate hCG in promoting oocyte maturation in a clinical in-vitro maturation programme: a randomized study.Hum Reprod,2003,18:2131-2136.
